Credit Agricole S A Voyager Therapeutics, Inc. Transaction History

Credit Agricole S A

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 14, 2019	SELL	$8.0 - $19.66 $365,600 - $898,462	-45,700 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$8.59 - $18.05 $859 - $1,805	100 Added 0.22%	45,700 $430,000
Q3 2018 Nov 13, 2018	BUY	$17.11 - $21.74 $188,210 - $239,139	11,000 Added 31.79%	45,600 $862,000
Q2 2018 Aug 10, 2018	BUY	$16.76 - $23.92 $579,896 - $827,632	34,600 New	34,600 $676,000

130

34.7M

39.7K

34.6K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $206M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Credit Agricole S A, based on Form 13F filings with the SEC.

Stay updated on Credit Agricole S A with notifications on news.